Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DSCI
2326
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $1.68M | ﹤0.01% |
541,800
+102,500
| +23% | +$343K |
|
|
CPL
2327
DELISTED
CPFL Energia S.A.
CPL
| $1.68M | ﹤0.01% |
157,759
+133,055
| +539% | +$1.12M |
|
|
PSTB
2328
DELISTED
Park Sterling Corp.
PSTB
| $1.68M | ﹤0.01% |
251,273
+32,550
| +15% | +$218K |
|
|
BREW
2329
DELISTED
Craft Brew Alliance, Inc.
BREW
| $1.67M | ﹤0.01% |
202,600
+19,200
| +10% | +$156K |
|
|
TULP
2330
Bloomia Holdings
TULP
| $1.66M | ﹤0.01% |
83,271
+1,300
| +2% | +$24.6K |
|
|
TREC
2331
DELISTED
Trecora Resources
TREC
| $1.66M | ﹤0.01% |
172,600
+36,300
| +27% | +$364K |
|
|
MBVT
2332
DELISTED
Merchants Bancshares Inc
MBVT
| $1.66M | ﹤0.01% |
55,800
+6,000
| +12% | +$174K |
|
2333
Analog Devices
ADI
$187B
| $1.66M | ﹤0.01% |
28,000
-1,408,400
| -98% | -$75.2M |
|
2334
Bristow Group
VTOL
$1.38B
| $1.66M | ﹤0.01% |
88,200
+65,300
| +285% | +$1.21M |
|
2335
Agilysys
AGYS
$3.2B
| $1.65M | ﹤0.01% |
161,700
+20,500
| +15% | +$208K |
|
|
MGI
2336
DELISTED
MoneyGram International, Inc. New
MGI
| $1.65M | ﹤0.01% |
268,791
+193,580
| +257% | +$1.09M |
|
|
BLUE
2337
DELISTED
bluebird bio
BLUE
| $1.64M | ﹤0.01% |
+2,980
| New | +$1.83M |
|
2338
Crawford & Co Class A
CRD.A
$631M
| $1.64M | ﹤0.01% |
272,400
+600
| +0.2% | +$2.85K |
|
|
ENZY
2339
DELISTED
Enzymotec Ltd
ENZY
| $1.63M | ﹤0.01% |
181,000
-36,700
| -17% | -$320K |
|
2340
Enanta Pharmaceuticals
ENTA
$387M
| $1.63M | ﹤0.01% |
+55,600
| New | +$1.55M |
|
|
TEP
2341
DELISTED
Tallgrass Energy Partners, LP
TEP
| $1.63M | ﹤0.01% |
+42,600
| New | +$1.49M |
|
|
PWOD
2342
DELISTED
Penns Woods Bancorp
PWOD
| $1.63M | ﹤0.01% |
63,450
+8,250
| +15% | +$215K |
|
2343
SiriusPoint
SPNT
$2.74B
| $1.63M | ﹤0.01% |
143,400
-111,900
| -44% | -$1.27M |
|
|
ACOR
2344
DELISTED
Acorda Therapeutics
ACOR
| $1.63M | ﹤0.01% |
513
-953
| -65% | -$3.96M |
|
|
RRTS
2345
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $1.63M | ﹤0.01% |
+5,228
| New | +$1.37M |
|
2346
Grupo SIMEC
SIM
$4.68B
| $1.63M | ﹤0.01% |
199,700
+7,700
| +4% | +$52.5K |
|
|
CCSC
2347
DELISTED
COUNTRY STYLE COOKING RESTAURANT CHAIN CO LTD ADS CAYMAN ISL
CCSC
| $1.63M | ﹤0.01% |
321,100
-40,100
| -11% | -$200K |
|
2348
Harte-Hanks
HHS
$32.1M
| $1.63M | ﹤0.01% |
64,320
+18,750
| +41% | +$576K |
|
2349
Pluri
PLUR
$18.6M
| $1.62M | ﹤0.01% |
12,585
-2,253
| -15% | -$212K |
|
|
FLNA
2350
Filana Therapeutics
FLNA
$44.3M
| $1.62M | ﹤0.01% |
103,855
+7,743
| +8% | +$100K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.